Works matching IS 03065251 AND DT 2021 AND VI 87 AND IP 9

Results: 32

Issue Highlights.

Published in:: British Journal of Clinical Pharmacology, 2021, v. 87, n. 9, p. 3383, doi. 10.1111/bcp.15036
Publication type:: Article

Science fiction has become reality: Best practice for future viral pandemics.

Published in:

British Journal of Clinical Pharmacology, 2021, v. 87, n. 9, p. 3385, doi. 10.1111/bcp.14997

By:

Wright, Daniel F. B.;
Kirkpatrick, Carl M. J.

Publication type:

Article

Traditional medicines for COVID‐19: Perspectives from clinical pharmacologists.

Published in:

British Journal of Clinical Pharmacology, 2021, v. 87, n. 9, p. 3455, doi. 10.1111/bcp.14981

By:

Yimer, Getnet;
Ekuadzi, Edmund;
Fasinu, Pius;
de Melo, Andreia Cristina;
Pillai, Goonaseelan

Publication type:

Article

Development, evaluation and use of COVID‐19 vaccines in older adults: Preliminary principles for the pandemic and beyond.

Published in:

British Journal of Clinical Pharmacology, 2021, v. 87, n. 9, p. 3459, doi. 10.1111/bcp.14967

By:

Hilmer, Sarah N.;
Petrovic, Mirko;
Le Couteur, David G.;
Schwartz, Janice B.;
Thuermann, Petra

Publication type:

Article

Blueprint for pandemic response: Focus on translational medicine, clinical pharmacology and pharmacometrics.

Published in:

British Journal of Clinical Pharmacology, 2021, v. 87, n. 9, p. 3398, doi. 10.1111/bcp.14859

By:

Davda, Jasmine;
Reynolds, Kellie;
Davis, John D.;
Smith, Patrick F.

Publication type:

Article

Bisphosphonate nephropathy: A case series and review of the literature.

Published in:

British Journal of Clinical Pharmacology, 2021, v. 87, n. 9, p. 3485, doi. 10.1111/bcp.14780

By:

de Roij van Zuijdewijn, Camiel;
van Dorp, Wim;
Florquin, Sandrine;
Roelofs, Joris;
Verburgh, Kees

Publication type:

Article

Nitrous oxide‐induced neurotoxicity: A case report and literature review.

Published in:

British Journal of Clinical Pharmacology, 2021, v. 87, n. 9, p. 3622, doi. 10.1111/bcp.14779

By:

Thayabaran, Darmiga;
Burrage, Daniel

Publication type:

Article

Adalimumab‐induced platelet antibodies resulting in severe thrombocytopenia.

Published in:

British Journal of Clinical Pharmacology, 2021, v. 87, n. 9, p. 3619, doi. 10.1111/bcp.14778

By:

Boiten, Henk‐Jan;
Amini, Sufia;
Wolfhagen, Frank H. J.;
Westerweel, Peter E.

Publication type:

Article

Modelling item scores of Unified Parkinson's Disease Rating Scale Part III for greater trial efficiency.

Published in:

British Journal of Clinical Pharmacology, 2021, v. 87, n. 9, p. 3608, doi. 10.1111/bcp.14777

By:

Sheng, Yucheng;
Zhou, Xuan;
Yang, Shuying;
Ma, Peiming;
Chen, Chao

Publication type:

Article

Clinical ophtalmo‐pharmacology. Looking ahead.

Published in:

British Journal of Clinical Pharmacology, 2021, v. 87, n. 9, p. 3483, doi. 10.1111/bcp.14776

By:

Cohen, Adam F.;
van Meurs, Jan C.

Publication type:

Article

Off‐label use of letrozole in Chinese short pubertal boys: Effectiveness, safety, and exposure–response analysis.

Published in:

British Journal of Clinical Pharmacology, 2021, v. 87, n. 9, p. 3599, doi. 10.1111/bcp.14775

By:

Xu, Yuan;
Zhang, Yan‐Hong;
Zhang, Qiu‐Ping;
Zhao, Qian‐Qian;
Cao, Xiao‐Fu;
Zhang, Mei;
Li, Xue;
Liu, Xi‐Ting;
Sun, Zhuo‐Xiang;
Kan, Min;
Du, Bin;
Zhou, Yue;
Yang, Fan;
Ban, Bo;
Zhao, Wei

Publication type:

Article

Sulfonylurea antidiabetics are associated with lower risk of out‐of‐hospital cardiac arrest: Real‐world data from a population‐based study.

Published in:

British Journal of Clinical Pharmacology, 2021, v. 87, n. 9, p. 3588, doi. 10.1111/bcp.14774

By:

Eroglu, Talip E.;
Jia, Lixia;
Blom, Marieke T.;
Verkerk, Arie O.;
Devalla, Harsha D.;
Boink, Gerard J.J.;
Souverein, Patrick C.;
de Boer, Anthonius;
Tan, Hanno L.

Publication type:

Article

Population pharmacokinetic modelling and simulation of tafamidis in healthy subjects and patients with transthyretin amyloidosis.

Published in:

British Journal of Clinical Pharmacology, 2021, v. 87, n. 9, p. 3574, doi. 10.1111/bcp.14773

By:

Huh, Yeamin;
Riley, Steve;
Harnisch, Lutz;
Nicholas, Timothy

Publication type:

Article

A randomized single and multiple ascending dose study in healthy volunteers of LTI‐291, a centrally penetrant glucocerebrosidase activator.

Published in:

British Journal of Clinical Pharmacology, 2021, v. 87, n. 9, p. 3561, doi. 10.1111/bcp.14772

By:

den Heijer, Jonas M.;
Kruithof, Annelieke C.;
van Amerongen, Guido;
de Kam, Marieke L.;
Thijssen, Eva;
Grievink, Hendrika W.;
Moerland, Matthijs;
Walker, Mike;
Been, Kees;
Skerlj, Renato;
Justman, Craig;
Dudgeon, Lindsay;
Lansbury, Peter;
Cullen, Valerie C.;
Hilt, Dana C.;
Groeneveld, Geert Jan

Publication type:

Article

Population pharmacokinetic analysis of RO5459072, a low water‐soluble drug exhibiting complex food–drug interactions.

Published in:

British Journal of Clinical Pharmacology, 2021, v. 87, n. 9, p. 3550, doi. 10.1111/bcp.14771

By:

Kratochwil, Nicole A.;
Stillhart, Cordula;
Diack, Cheikh;
Nagel, Sandra;
Al Kotbi, Nada;
Frey, Nicolas

Publication type:

Article

Implications of a defined daily dose fixed database for drug utilization research studies: The case of statins in Portugal.

Published in:

British Journal of Clinical Pharmacology, 2021, v. 87, n. 9, p. 3542, doi. 10.1111/bcp.14770

By:

Abrantes, Catarina;
Tonin, Fernanda S.;
Reis‐Pardal, Joana;
Castel‐Branco, Margarida;
Furtado, Claudia;
Figueiredo, Isabel V.;
Fernandez‐Llimos, Fernando

Publication type:

Article

Population pharmacokinetics and pharmacodynamics of Tranexamic acid in women undergoing caesarean delivery.

Published in:

British Journal of Clinical Pharmacology, 2021, v. 87, n. 9, p. 3531, doi. 10.1111/bcp.14767

By:

Li, Shuhui;
Ahmadzia, Homa K.;
Guo, Dong;
Dahmane, Elyes;
Miszta, Adam;
Luban, Naomi L.C.;
Berger, Jeffrey S.;
James, Andra H.;
Wolberg, Alisa S.;
van den Anker, John N.;
Gobburu, Jogarao V.S.

Publication type:

Article

Improved estimates of mean pharmacokinetic parameters for increased accuracy in dosing and reduced risk to patients.

Published in:

British Journal of Clinical Pharmacology, 2021, v. 87, n. 9, p. 3518, doi. 10.1111/bcp.14766

By:

Scutt, Greg;
Waxman, David

Publication type:

Article

Software to predict the right dose for vancomycin in a clinical environment—A commentary on: Personalised dosing of vancomycin: A prospective and retrospective comparative quasi‐experimental study by Luqman Vali et al.

Published in:

British Journal of Clinical Pharmacology, 2021, v. 87, n. 9, p. 3481, doi. 10.1111/bcp.14765

By:

Dijkstra, Jacob A.;
Veldkamp, Agnes I.;
Sieswerda, Elske;
van Agtmael, Michiel

Publication type:

Article

Impact of anticoagulant exposure misclassification on the bleeding risk of direct oral anticoagulants.

Published in:

British Journal of Clinical Pharmacology, 2021, v. 87, n. 9, p. 3508, doi. 10.1111/bcp.14764

By:

Hempenius, Mirjam;
Groenwold, Rolf H. H.;
Souverein, Patrick C.;
de Boer, Anthonius;
Klungel, Olaf H.;
Gardarsdottir, Helga

Publication type:

Article

Postvaccination anaphylaxis and mRNA‐based SARS‐CoV‐2 vaccines—Much ado about nothing?

Published in:

British Journal of Clinical Pharmacology, 2021, v. 87, n. 9, p. 3632, doi. 10.1111/bcp.14763

By:

Marcec, Robert;
Likic, Robert

Publication type:

Article

Comment on the article by Eshetie et al. entitled "Potentially inappropriate medication use and related hospital admissions in aged care residents: The impact of dementia".

Published in:

British Journal of Clinical Pharmacology, 2021, v. 87, n. 9, p. 3628, doi. 10.1111/bcp.14761

By:

Isaia, Gianluca;
Brunetti, Enrico;
Bo, Mario

Publication type:

Article

Model‐informed drug repurposing: A pharmacometric approach to novel pathogen preparedness, response and retrospection.

Published in:

British Journal of Clinical Pharmacology, 2021, v. 87, n. 9, p. 3388, doi. 10.1111/bcp.14760

By:

Dodds, Michael;
Xiong, Yuan;
Mouksassi, Samer;
Kirkpatrick, Carl M.;
Hui, Katrina;
Doyle, Eileen;
Patel, Kashyap;
Cox, Eugène;
Wesche, David;
Brown, Fran;
Rayner, Craig R.

Publication type:

Article

Phase I evaluation of pharmacokinetics and tolerability of the HIV‐1 maturation inhibitor GSK3640254 and dolutegravir in healthy adults.

Published in:

British Journal of Clinical Pharmacology, 2021, v. 87, n. 9, p. 3501, doi. 10.1111/bcp.14759

By:

Pene Dumitrescu, Teodora;
Joshi, Samit R.;
Xu, Jianfeng;
Greene, Thomas J.;
Johnson, Mark;
Butcher, Laurie;
Zimmerman, Eric;
Webster, Lindsey;
Pham, Theresa T.;
Lataillade, Max;
Min, Sherene

Publication type:

Article

Relationship among genetic polymorphism of SLCO1B1, rifampicin exposure and clinical outcomes in patients with active pulmonary tuberculosis.

Published in:

British Journal of Clinical Pharmacology, 2021, v. 87, n. 9, p. 3492, doi. 10.1111/bcp.14758

By:

Kim, Eun Sun;
Kwon, Byoung Soo;
Park, Jong Sun;
Chung, Jae‐Yong;
Seo, Soo Hyun;
Park, Kyoung Un;
Song, Junghan;
Yoon, Seonghae;
Lee, Jae Ho

Publication type:

Article

Using in silico viral kinetic models to guide therapeutic strategies during a pandemic: An example in SARS‐CoV‐2.

Published in:

British Journal of Clinical Pharmacology, 2021, v. 87, n. 9, p. 3425, doi. 10.1111/bcp.14718

By:

Patel, Kashyap;
Dodds, Michael;
Gonçalves, Antonio;
Kamal, Mohamed A.;
Rayner, Craig R.;
Kirkpatrick, Carl M.;
Smith, Patrick F.

Publication type:

Article

Response to Van De Sijpe et al.: Preventing medication‐related harm: Perfect is the enemy of the good.

Published in:

British Journal of Clinical Pharmacology, 2021, v. 87, n. 9, p. 3627, doi. 10.1111/bcp.14701

By:

Loke, Yoon Kong;
Mattishent, Katharina

Publication type:

Article

Racing to immunity: Journey to a COVID‐19 vaccine and lessons for the future.

Published in:

British Journal of Clinical Pharmacology, 2021, v. 87, n. 9, p. 3408, doi. 10.1111/bcp.14686

By:

Calvo Fernández, Ester;
Zhu, Lucie Y.

Publication type:

Article

Risk assessment of therapeutic agents under consideration to treat COVID‐19 in paediatric patients and pregnant women.

Published in:: British Journal of Clinical Pharmacology, 2021, v. 87, n. 9, p. 3462, doi. 10.1111/bcp.14630
Publication type:: Article

Model‐informed drug repurposing: Viral kinetic modelling to prioritize rational drug combinations for COVID‐19.

Published in:

British Journal of Clinical Pharmacology, 2021, v. 87, n. 9, p. 3439, doi. 10.1111/bcp.14486

By:

Dodds, Michael G.;
Krishna, Rajesh;
Goncalves, Antonio;
Rayner, Craig R.

Publication type:

Article

Issue Information.

Published in:: British Journal of Clinical Pharmacology, 2021, v. 87, n. 9, p. 3381, doi. 10.1111/bcp.14383
Publication type:: Article

Dosing will be a key success factor in repurposing antivirals for COVID‐19.

Published in:

British Journal of Clinical Pharmacology, 2021, v. 87, n. 9, p. 3451, doi. 10.1111/bcp.14314

By:

Smith, Patrick F.;
Dodds, Michael;
Bentley, Darren;
Yeo, Karen;
Rayner, Craig

Publication type:

Article